CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress

  1. Shah, M.
  2. Grothey, A.
  3. Tebbutt, N.
  4. Xu, R.
  5. Yoshino, T.
  6. Cervantes, A.
  7. Tabernero, J.
  8. Taieb, J.
  9. Falcone, A.
  10. Xu, B.
  11. Fontaine, M.
  12. Borodyansky, L.
  13. Van Cutsem, E.
Aldizkaria:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Argitalpen urtea: 2018

Alea: 29

Orrialdeak: v84

Mota: Artikulua

DOI: 10.1093/ANNONC/MDY151.296 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus